Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 May;33(5):470-480.
doi: 10.1007/s00380-017-1082-4. Epub 2017 Nov 20.

A cross-sectional and longitudinal study between association of n-3 polyunsaturated fatty acids derived from fish consumption and high-density lipoprotein heterogeneity

Affiliations

A cross-sectional and longitudinal study between association of n-3 polyunsaturated fatty acids derived from fish consumption and high-density lipoprotein heterogeneity

Shigemasa Tani et al. Heart Vessels. 2018 May.

Abstract

Decreased high-density lipoprotein (HDL) particle size, cholesterol poor, apolipoprotein A-I-rich HDL particles leading to smaller HDL particle size, may be associated with an anti-atherosclerotic effect. The data are sparse regarding the relationship between n-3 polyunsaturated fatty acids [n-3 PUFAs: eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA)] and HDL particle size. This study was designed as a hospital-based cross-sectional study to investigate the relationship between the serum levels of n-3 PUFAs and the HDL-cholesterol/apolipoprotein A-1 ratio, as estimated by the HDL particle size, in patients with the presence of one or more risk factors for atherosclerotic cardiovascular disease (ASCVD). Six hundred and forty sequential patients were enrolled in this study. The serum levels of EPA and DHA showed a strong correlation (r = 0.736, p < 0.0001). However, in a multivariate regression analysis after adjustment for ASCVD risk factors, increased serum DHA (β = - 0.745, p = 0.021), but not serum EPA (β = - 0.414, p = 0.139) or EPA + DHA (β = 0.330, p = 0.557) level, was identified as an independent indicator of decreased HDL particle size. In 476 patients followed up for at least 6 months, the absolute change (Δ) in the HDL-cholesterol/apolipoprotein A-1 ratio decreased significantly as the quartile of the Δ DHA level increased (p = 0.014), whereas no significant difference in the Δ HDL-cholesterol/apolipoprotein A-1 ratio was noted with the increase in the quartile of the Δ EPA level. Moreover, a multivariate regression analysis identified increased DHA level and decreased estimated low-density lipoprotein (LDL) particle size measured relative to the mobility value of LDL with polyacrylamide gel electrophoresis (i.e., relative LDL migration: LDL-Rm value), as independent predictors of decreased HDL-cholesterol/apolipoprotein A-1 ratio (β = - 0.171, p = 0.0003 and β = - 0.142, p = 0.002). The results suggest that increased serum DHA level, but not EPA level, might be associated with decreased HDL-cholesterol/apolipoprotein A-1 ratio, an indicator of estimated HDL particle size. Further studies are needed to investigate the useful clinical indices and outcomes of these patients. Clinical Trial Registration Information UMIN ( http://www.umin.ac.jp/ ), Study ID: UMIN000010603.

Keywords: Apolipoprotein A-1; Docosahexaenoic acid; Eicosapentaenoic acid; High-density lipoprotein; n-3 Polyunsaturated fatty acid.

PubMed Disclaimer

Conflict of interest statement

S Tani has received scholarship from Takeda Pharmaceuticial Company Ltd. and Mochida Pharmaceuticial Company Ltd.

Figures

Fig. 1
Fig. 1
Association of the HDL-C/apoA-1 ratio with the serum DHA level. The patients were divided into quartiles of the DHA concentration. The DHA according to quartile was as follows: 35.7–100.7 μg/mL (quartile 1: n = 160), 100.8–128.7 μg/mL (quartile 2: n = 160), 128.9–160.5 μg/mL (quartile 3: n = 160), and 160.7–451.8 μg/mL (quartile 4: n = 160). The serum HDL-C level tended to increase as the serum DHA quartile increased, but it did not reach statistical significance. While the serum apoA-1 level increased significantly as the serum DHA quartile increased. The serum HDL-C/apoA-1 ratio accordingly decreased significantly as the serum DHA quartile increased. HDL-C high-density lipoprotein cholesterol, apoA-1 apolipoprotein A-1, DHA docosahexaenoic acid
Fig. 2
Fig. 2
Association of the HDL-C/apoA-1 ratio with the serum EPA level. The patients were divided into quartiles of the EPA concentration. The ranges according to the quartile of EPA were follows: 6.2–40.0 μg/mL (quartile 1: n = 160), 40.1–62.8 μg/mL (quartile 2: n = 160), 63.0–92.2 μg/mL (quartile 3: n = 160), and 92.4–373.5 μg/mL (quartile 4: n = 160). The serum HDL-C level increased significantly as the serum EPA quartile increased, while the serum apoA-1 level also increased significantly as the serum EPA quartile increased. Accordingly, no significant change in the serum HDL-C/apoA-1 ratio is found as the serum EPA quartile increased. HDL-C high-density lipoprotein cholesterol, apoA-1 apolipoprotein A-1, EPA eicosapentaenoic acid
Fig. 3
Fig. 3
Association of the Δ HDL-C/apoA-1 ratio with the Δ serum DHA level. The Δ HDL-C/apoA-1 ratio correlated negatively with the Δ DHA level. Similarly, the Δ HDL-C/apoA-1 ratio decreased significantly as the Δ DHA quartile increased. HDL-C high-density lipoprotein cholesterol, apoA-1 = apolipoprotein A-1, DHA docosahexaenoic acid, Δ absolute change from baseline to 6-month follow-up
Fig. 4
Fig. 4
Title: Association between the HDL-C/apoA-1 ratio and LDL-Rm value associated, an indicator of LDL particle size with the serum TG level. HDL-C high-density lipoprotein cholesterol, apoA-1 apolipoprotein A-1, LDL-Rm relative LDL migration, TG triglyceride, Δ absolute change from baseline to 6-month follow-up
Fig. 5
Fig. 5
Association between HDL-C/apoA-1 ratio AND LDL-Rm value. A positive correlation was observed between the LDL-Rm value and HDL-C/apoA-1, and the ∆ LDL-Rm value was also found to be weakly correlated with the ∆ HDL-C/apoA-1 ratio. HDL-C high-density lipoprotein cholesterol, apoA-1 apolipoprotein A-1, LDL-Rm relative LDL migration, Δ absolute change from baseline to 6-month follow-up

References

    1. http://www.jfa.maff.go.jp/j/kikaku/wpaper/h22_h/trend/1/t1_2_1_1.html. Accessed 11 July 2014
    1. Iso H, Kobayashi M, Ishihara J, Sasaki S, Okada K, Kita Y, Kokubo Y, Tsugane S, JPHC Study Group Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based (JPHC) Study Cohort I. Circulation. 2006;113:195–202. doi: 10.1161/CIRCULATIONAHA.105.581355. - DOI - PubMed
    1. Mozaffarian D, Wu JH. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol. 2011;58:2047–2067. doi: 10.1016/j.jacc.2011.06.063. - DOI - PubMed
    1. Rader DJ, Hovingh GK. HDL and cardiovascular disease. Lancet. 2014;384:618–625. doi: 10.1016/S0140-6736(14)61217-4. - DOI - PubMed
    1. Tani S, Nagao K, Hirayama A. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol. Am J Cardiovasc Drugs. 2011;11:411–417. doi: 10.2165/11594620-000000000-00000. - DOI - PubMed